[Pilot clinical trial of ladasten].
Siuniakov SA, Grishin SA, Teleshova ES, Neznamov GG, Seredenin SB · 2006 · Eksperimental'naia i klinicheskaia farmakologiia; 2006 Jul-Aug
Study findings
An early clinical report describes stimulant and anxiolytic effects in patients with psychogenic asthenia. The abstract does not provide sample size, allocation details or numerical treatment effects.
- Population and setting
- Patients; see abstract scope
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Original full text and detailed methods have not been reviewed.
- Sample size, allocation, masking and numerical outcomes require full-text appraisal; the report cannot establish effects in healthy users.
- Possible overlap with other Ladasten neurasthenia reports, including the existing clinical program, remains unresolved; do not count this as independent replication.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Siuniakov SA, Grishin SA, Teleshova ES, Neznamov GG, Seredenin SB. [Pilot clinical trial of ladasten]. Eksperimental'naia i klinicheskaia farmakologiia; 2006 Jul-Aug 2006.
Molekul research summary: https://molekul.io/research/brom-extra-16995430. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry